| Primary |
| Respiratory Failure |
23.1% |
| Agitation |
7.7% |
| Anxiety |
7.7% |
| Gastric Disorder |
7.7% |
| Pneumonia |
7.7% |
| Product Used For Unknown Indication |
7.7% |
| Pulmonary Embolism |
7.7% |
| Pyrexia |
7.7% |
| Acinetobacter Infection |
3.8% |
| Acute Myeloid Leukaemia |
3.8% |
| Diabetic Foot Infection |
3.8% |
| Osteomyelitis |
3.8% |
| Pneumonia Primary Atypical |
3.8% |
| Sepsis |
3.8% |
|
| Haemolysis |
15.4% |
| Bronchospasm |
7.7% |
| Delirium |
7.7% |
| Drug Hypersensitivity |
7.7% |
| Hallucination |
7.7% |
| Laryngeal Oedema |
7.7% |
| Melaena |
7.7% |
| Product Substitution Issue |
7.7% |
| Rash |
7.7% |
| Renal Failure Acute |
7.7% |
| Tachypnoea |
7.7% |
| Vomiting |
7.7% |
|
| Secondary |
| Product Used For Unknown Indication |
37.0% |
| Hypertension |
11.6% |
| Bacteraemia |
8.9% |
| Pneumonia |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Drug Use For Unknown Indication |
3.5% |
| Pain |
3.3% |
| Pneumonia Mycoplasmal |
3.2% |
| Prophylaxis |
2.8% |
| Infection |
2.7% |
| Sepsis |
2.7% |
| Depression |
2.6% |
| Pneumonia Primary Atypical |
2.4% |
| Toxic Epidermal Necrolysis |
2.2% |
| Psoas Abscess |
2.0% |
| Antibiotic Therapy |
1.7% |
| Hyperlipidaemia |
1.6% |
| Infection Prophylaxis |
1.5% |
| Pyrexia |
1.5% |
| Bronchitis Chronic |
1.4% |
|
| Toxic Epidermal Necrolysis |
30.7% |
| Toxic Skin Eruption |
6.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.7% |
| Febrile Neutropenia |
5.7% |
| Sepsis |
5.7% |
| Stevens-johnson Syndrome |
5.7% |
| Renal Failure Acute |
4.5% |
| Skin Exfoliation |
4.5% |
| Thrombocytopenia |
4.5% |
| Gastritis |
3.4% |
| Aphasia |
2.3% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.3% |
| Hypotension |
2.3% |
| Leukocytosis |
2.3% |
| Movement Disorder |
2.3% |
| Neutropenia |
2.3% |
| Pneumonia Fungal |
2.3% |
| Pyrexia |
2.3% |
| Septic Embolus |
2.3% |
| Septic Shock |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.8% |
| Drug Use For Unknown Indication |
18.4% |
| Prophylaxis |
7.7% |
| Infection |
3.1% |
| Infection Prophylaxis |
3.1% |
| Sepsis |
2.9% |
| Hypertension |
2.7% |
| Pneumonia |
2.7% |
| Acute Myeloid Leukaemia |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Immunosuppression |
1.7% |
| Pyrexia |
1.7% |
| Stem Cell Transplant |
1.5% |
| Chronic Lymphocytic Leukaemia |
1.5% |
| Multiple Myeloma |
1.5% |
| Hiv Infection |
1.4% |
| Nausea |
1.4% |
| Neoplasm Malignant |
1.4% |
| Prophylaxis Against Renal Transplant Rejection |
1.4% |
| Acute Lymphocytic Leukaemia |
1.4% |
|
| Vomiting |
16.0% |
| Renal Failure Acute |
8.0% |
| Septic Shock |
8.0% |
| Sepsis |
7.4% |
| Pyrexia |
5.7% |
| Renal Failure |
5.7% |
| Shock |
5.7% |
| Thrombocytopenia |
4.0% |
| Tracheo-oesophageal Fistula |
4.0% |
| Weight Decreased |
4.0% |
| Death |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Ventricular Tachycardia |
3.4% |
| Weight Increased |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Acute Respiratory Distress Syndrome |
2.9% |
| Drug Ineffective |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Neutropenia |
2.9% |
| Pneumonia |
2.9% |
|
| Interacting |
| Urinary Tract Infection |
26.7% |
| Angina Pectoris |
13.3% |
| Pneumonia Aspiration |
13.3% |
| Cardiac Failure |
6.7% |
| Coronary Artery Disease |
6.7% |
| Gastrooesophageal Reflux Disease |
6.7% |
| Hypertension |
6.7% |
| Ischaemic Heart Disease Prophylaxis |
6.7% |
| Pain |
6.7% |
| Parkinson's Disease |
6.7% |
|
|
